TY - JOUR
T1 - Uterine neoplasms, version 3.2021 featured updates to the NCCN guidelines
AU - Abu-Rustum, Nadeem R.
AU - Yashar, Catheryn M.
AU - Bradley, Kristin
AU - Campos, Susana M.
AU - Chino, Junzo
AU - Chon, Hye Sook
AU - Chu, Christina
AU - Cohn, David
AU - Crispens, Marta Ann
AU - Damast, Shari
AU - Diver, Elisabeth
AU - Fisher, Christine M.
AU - Frederick, Peter
AU - Gaffney, David K.
AU - George, Suzanne
AU - Giuntoli, Robert
AU - Han, Ernest
AU - Howitt, Brooke
AU - Huh, Warner K.
AU - Lea, Jayanthi
AU - Mariani, Andrea
AU - Mutch, David
AU - Nekhlyudov, Larissa
AU - Podoll, Mirna
AU - Remmenga, Steven W.
AU - Kevin Reynolds, R.
AU - Salani, Ritu
AU - Sisodia, Rachel
AU - Soliman, Pamela
AU - Tanner, Edward
AU - Ueda, Stefanie
AU - Urban, Renata
AU - Wethington, Stephanie L.
AU - Wyse, Emily
AU - Zanotti, Kristine
AU - McMillian, Nicole R.
AU - Motter, Angela D.
N1 - Funding Information:
This activity is supported by educational grants from Agios Pharmaceuticals; AstraZeneca; Clovis Oncology, Inc.; Daiichi Sankyo; Eisai; Epizyme Inc.; Novartis; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. This activity is supported by an independent medical education grant from Bristol-Myers Squibb, and Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is supported by an independent medical educational grant from Mylan Inc. This activity is supported by a medical education grant from Karyopharm Therapeutics.
Publisher Copyright:
© National Comprehensive Cancer Network, Inc. 2021.
PY - 2021/8
Y1 - 2021/8
N2 - The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas.
AB - The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas.
UR - http://www.scopus.com/inward/record.url?scp=85113348043&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2021.0038
DO - 10.6004/jnccn.2021.0038
M3 - Review article
C2 - 34416706
AN - SCOPUS:85113348043
VL - 19
SP - 889
EP - 895
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
SN - 1540-1405
IS - 8
ER -